Efficacy assessments will occur on a monthly basis (28 days, designated as Study Day) for the first 12 months then on a 2-months basis thereafter, regardless of current cycle day, and can be performed within 3 days to day one of the cycle. Study of vital signs and performance status is requested at Study Day.